Pharma: Other News To Note
Tuesday, July 3, 2012
K-V Pharmaceutical Co., of St. Louis, said the FDA provided further guidance to health care providers and pregnant women at high risk for recurrent preterm birth.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.